One in eight young women with acute Myocardial Infarction (MI) have a type of MI that falls in the “unclassified” category under a current classification system, researchers report; they propose a new taxonomy that better captures different presentations in young women.
The US Preventive Services Task Force (USPSTF) advised in its final recommendation statement on smoking cessation in adults that clinicians should ask all adults about their tobacco use, advise them to quit if they do smoke, and provide evidence-based behavioral therapies and medications to help them quit.
The American College of Cardiology, American Heart Association, and the Heart Rhythm Society (ACC/AHA/HRS) have published new guidelines for the management of patients with supraventricular tachycardia (SVT).
The European Medicines Agency (EMA) has recommended the approval a specific antidote to reverse the anticoagulant effect of the direct oral thrombin inhibitor dabigatran (Pradaxa): idarucizumab (Praxbind, Boehringer Ingelheim).
According a new research, overingestion of two factor Xa inhibitors is rarely associated with serious bleeding in adults — and has no association with toxicity in kids who accidently take the drugs.
The adipokines adiponectin and resistin, a obesity-related proteins show potential as novel biomarkers for acute pain associated with migraine severity, as well as treatment response, new data suggest.
A a small study shows that patients with fibromyalgia show deficiencies in red blood cell (RBC) magnesium and insulin-like growth factor 1 (IGF-1), suggesting potential clues to underpinnings of the condition and avenues for treatment.
Antibiotic resistance rates across the globe are alarming, and the only sustainable solutions are to limit overuse and misuse of antibiotics, according to the Center for Disease Dynamics, Economics & Policy (CDDEP).
Metformin-related vitamin B12 deficiency might contribute to clinically significant peripheral neuropathy in diabetes patients, new research suggests.
In a randomized trial, spironolactone was the winner. Spironolactone was the clear “winner” in this valuable study of resistant hypertension; the inverse relation with baseline PRA suggests that its efficacy is related, at least in part, to enhanced natriuresis.
A new report provides details on 45 individuals from 13 countries who developed a chronic ailment soon after receiving the human papillomavirus (HPV) vaccine.